Literature DB >> 26255211

Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Jing Zhou1, Jun-O Jin2, Ekta S Patel3, Qing Yu4.   

Abstract

Interleukin (IL)-6 is a multi-functional cytokine that can either promote or suppress tissue inflammation depending on the specific disease context. IL-6 is elevated in the exocrine glands and serum of patients with Sjögren's syndrome (SS), but the specific role of IL-6 in the pathogenesis of this disease has not been defined. In this study, we showed that IL-6 expression levels were increased with age in C56BL/6.NOD-Aec1Aec2 mice, a primary SS model, and higher than the control C57BL/6 mice. To assess the role of IL-6 during the immunological phase of SS development, a neutralizing anti-IL-6 antibody was administered into 16 week-old female C56BL/6.NOD-Aec1Aec2 mice, 3 times weekly for a consecutive 8 weeks. Neutralization of endogenous IL-6 throughout the immunological phase of SS development led to increased apoptosis, caspase-3 activation, leukocytic infiltration, and IFN-γ- and TNF-α production in the salivary gland. To further determine the effect of IL-6 on the apoptosis of exocrine gland cells, recombinant human IL-6 or the neutralizing anti-IL-6 antibody was injected into female C57BL/6 mice that received concurrent injection of anti-CD3 antibody to induce the apoptosis of exocrine gland tissues. Neutralization of IL-6 enhanced, whereas administration of IL-6 inhibited apoptosis and caspase-3 activation in salivary and lacrimal glands in this model. The apoptosis-suppressing effect of IL-6 was associated with up-regulation of Bcl-xL and Mcl-1 in both glands. Moreover, IL-6 treatment induced activation of STAT3 and up-regulated Bcl-xL and Mcl-1 gene expression in a human salivary gland epithelial cell line. In conclusion, IL-6 inhibits the apoptosis of exocrine gland tissues and exerts a tissue-protective effect under inflammatory conditions including SS. These findings suggest the possibility of using this property of IL-6 to preserve exocrine gland tissue integrity and function under autoimmune and inflammatory conditions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Exocrine gland; Inflammation; Interleukin-6; Sjögren’s syndrome

Mesh:

Substances:

Year:  2015        PMID: 26255211      PMCID: PMC4605873          DOI: 10.1016/j.cyto.2015.07.027

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  62 in total

1.  Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

Authors:  J M van Woerkom; A A Kruize; M J G Wenting-van Wijk; E Knol; I C Bihari; J W G Jacobs; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

Review 2.  IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

Authors:  Markus F Neurath; Susetta Finotto
Journal:  Cytokine Growth Factor Rev       Date:  2011-03-05       Impact factor: 7.638

3.  Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.

Authors:  N Ishimaru; K Saegusa; K Yanagi; N Haneji; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  Interleukin-6-induced protection in hyperoxic acute lung injury.

Authors:  N S Ward; A B Waxman; R J Homer; L L Mantell; O Einarsson; Y Du; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  2000-05       Impact factor: 6.914

5.  Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.

Authors:  Mikihito Kajiya; Isao Ichimonji; Christine Min; Tongbo Zhu; Jun-O Jin; Qing Yu; Soulafa A Almazrooa; Seunghee Cha; Toshihisa Kawai
Journal:  Mol Pharmacol       Date:  2012-04-17       Impact factor: 4.436

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome.

Authors:  Jun-O Jin; Qing Yu
Journal:  J Clin Cell Immunol       Date:  2013-02-26

8.  Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

Authors:  Cuong Q Nguyen; Min H Hu; Yi Li; Carol Stewart; Ammon B Peck
Journal:  Arthritis Rheum       Date:  2008-03

9.  Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.

Authors:  Anne Isine Bolstad; Hans Geir Eiken; Benedikte Rosenlund; Marta E Alarcón-Riquelme; Roland Jonsson
Journal:  Arthritis Rheum       Date:  2003-01

10.  p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.

Authors:  Ahmed Fahmi; Nicola Smart; Anu Punn; Rita Jabr; Michael Marber; Richard Heads
Journal:  Cell Signal       Date:  2012-12-23       Impact factor: 4.315

View more
  2 in total

1.  Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway.

Authors:  Mei-Fang Nie; Qi Xie; Ya-Hong Wu; Hua He; Lu-Jie Zou; Xiao-Ling She; Xian-Qing Wu
Journal:  J Immunol Res       Date:  2018-09-12       Impact factor: 4.818

2.  Deciphering Molecular and Phenotypic Changes Associated with Early Autoimmune Disease in the Aire-Deficient Mouse Model of Sjögren's Syndrome.

Authors:  Feeling YuTing Chen; Eliza Gaylord; Nancy McNamara; Sarah Knox
Journal:  Int J Mol Sci       Date:  2018-11-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.